Skip to main content

Educational videos

Filter by

Evolutions in Gastroparesis and Gastric Electrical Stimulation: The past, present and future

A multi-part video series to help you gain insights into gastroparesis and gastric electrical stimulation.

Tell me about the surgical options you consider once conservative therapy has failed and why…

0:1:53
Watch recording

Tell me about gastric electrical stimulation (GES) and where it benefits patients most…

0:5:40
Watch recording

Tell me about current data on GES and what it means for patient care…

0:4:10
Watch recording

Tell me about how you counsel your patients on the long-term efficacy of various gastroparesis treatments…

0:5:41
Watch recording
IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?